A Phase 1, First Time in Humans Study of NST-1024

Clinical trial NCT04630366 · COMPLETED

Trial details

NCT number: NCT04630366
Sponsor: NorthSea Therapeutics B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertriglyceridemia

Start date: 2020-10-27
Primary completion: 2022-06-20
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.